Opti Capital Management, LP Gossamer Bio, Inc. Transaction History
Opti Capital Management, LP
- $1.63 Trillion
- Q1 2025
A detailed history of Opti Capital Management, LP transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Opti Capital Management, LP holds 414,152 shares of GOSS stock, worth $480,416. This represents 0.03% of its overall portfolio holdings.
Number of Shares
414,152
Previous 182,319
127.16%
Holding current value
$480,416
Previous $165 Million
176.23%
% of portfolio
0.03%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding GOSS
# of Institutions
127Shares Held
162MCall Options Held
2.11MPut Options Held
57.8K-
Octagon Capital Advisors LP New York, NY18.4MShares$21.3 Million6.72% of portfolio
-
Nea Management Company, LLC Timonium, MD18.1MShares$21 Million1.89% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$11.7 Million0.0% of portfolio
-
Arch Venture Management, LLC Chicago, IL8.06MShares$9.34 Million7.27% of portfolio
-
Acadian Asset Management LLC Boston, MA6.36MShares$7.38 Million0.02% of portfolio
About Gossamer Bio, Inc.
- Ticker GOSS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,954,000
- Market Cap $109M
- Description
- Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...